Delivery Order SPE2DB22D1103-SPE2DB25FTGP6

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is for the delivery of Clarithromycin 500 mg tablets to the Defense Logistics Agency (DLA). The $3,167.68 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,754.67 firm fixed-price delivery order is for the supply of Clarithromycin 500 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Clarithromycin 500 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,083.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,753.02 firm fixed-price delivery order is for the supply of 4,562,834,751 units of Clarithromycin 500 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen, valued at up to $999,999,999.00, which runs through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,765.95 firm fixed-price delivery order is for the supply of Clarithromycin 500 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,563.84 firm fixed-price delivery order is for the supply of Clarithromycin 500 mg tablets. The contract has an ultimate completion date of February 10, 2025 and was awarded on February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,045.48 Firm Fixed Price Delivery Order is for the supply of 4,562,926,658 tablets of the antibiotic Clarithromycin 500 mg. The contract has an ultimate completion date of November 30, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of clarithromycin 500 mg tablets. The contract, valued at $4,388.49, was awarded on May 8, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation mentioned for this award. Amerisourcebergen, one of the largest pharmaceutical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,407.61, is for the supply of Clarithromycin 500 mg tablets. It is a Firm Fixed Price contract with a completion date of November 22, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.27 firm fixed-price delivery order contract is for the supply of Clarithromycin 500 mg tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTGP6
    Delivery Order

This federal contract award is for the delivery of Clarithromycin 500 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,724.54, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order that runs through March 7, 2025. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 6/5/25, 9:58 AM